Stocks and Investing Stocks and Investing
Mon, March 8, 2021
Fri, March 5, 2021
Thu, March 4, 2021
Wed, March 3, 2021
Tue, March 2, 2021

Andrew Berens Maintained (AZN) at Buy with Decreased Target to $63 on, Mar 2nd, 2021


Published on 2024-10-27 15:49:03 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "AstraZeneca PLC" (AZN) at Buy with Decreased Target from $64 to $63 on, Mar 2nd, 2021.

Andrew has made no other calls on AZN in the last 4 months.



There are 2 other peers that have a rating on AZN. Out of the 2 peers that are also analyzing AZN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Michael Leuchten of "UBS" Upgraded from Hold to Strong Buy on, Thursday, February 25th, 2021
  • Emmanuel Papadakis of "Deutsche Bank" Initiated at Strong Buy on, Friday, January 15th, 2021